Recurrent airway obstruction - Heaves

Veterinary Clinics of North America - Equine Practice

Volumn 19, Issue 1, 2003, Pages 63-86

  Léguillette, Renaud ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ATROPINE; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BRONCHODILATING AGENT; CLENBUTEROL; CORTICOSTEROID; DEXAMETHASONE; DEXAMETHASONE ISONICOTINATE; FLUTICASONE PROPIONATE; IPRATROPIUM BROMIDE; ISOFLUPREDONE; ISOFLUPREDONE ACETATE; PENTOXIFYLLINE; PREDNISOLONE; SALBUTAMOL; THEOPHYLLINE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ABDOMINAL WALL MUSCULATURE; AIRWAY OBSTRUCTION; ASPERGILLUS FUMIGATUS; BRONCHODILATATION; BRONCHOSPASM; CLINICAL EXAMINATION; COUGHING; CYTODIAGNOSIS; CYTOKINE RELEASE; DRUG BIOAVAILABILITY; DRUG MECHANISM; DUST; EXERCISE TOLERANCE; EXPIRATORY FLOW; HORSE DISEASE; HYPOXEMIA; IMMUNE RESPONSE; INFLAMMATION; INTERSTITIAL PNEUMONIA; LUNG AUSCULTATION; LUNG FIBROSIS; LUNG FUNCTION; LUNG INJURY; LUNG LAVAGE; MICROPOLYSPORA FAENI; MUCUS SECRETION; MUSCLE HYPERTROPHY; NEUTROPHIL; NONHUMAN; NOSE SECRETION; PATHOGENESIS; PREVALENCE; PROGNOSIS; RESPIRATORY AIRFLOW; RESPIRATORY DISTRESS; REVIEW; THERMOACTINOMYCES VULGARIS; THORAX RADIOGRAPHY; VIRUS INFECTION; WHEEZING; ANIMAL; ANIMAL DISEASE; CHRONIC DISEASE; HORSE; LUNG FUNCTION TEST; METABOLISM; MUCUS; PATHOLOGY; RECURRENT DISEASE; RESPIRATORY TRACT ALLERGY;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; EQUUS CABALLUS; NOCARDIA; SACCHAROPOLYSPORA RECTIVIRGULA; THERMOACTINOMYCES; THERMOACTINOMYCES VULGARIS;

ADRENAL CORTEX HORMONES; AIRWAY OBSTRUCTION; ANIMALS; BRONCHOALVEOLAR LAVAGE; CHRONIC DISEASE; HORSE DISEASES; HORSES; MUCUS; PROGNOSIS; RECURRENCE; RESPIRATORY FUNCTION TESTS; RESPIRATORY HYPERSENSITIVITY;

EID: 3242736823     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0739(02)00067-6     Document Type: Review

References (109)

1. Robinson N.E. International workshop on equine chronic airway disease. Equine Vet J. 33:2001;5-19
2. Lowell F.C. Observations on heaves. An asthma-like syndrome in the horse. Allergy Proc. 11:1990;147-150
3. Traub-Dargatz J.L., Salman M.D., Voss J.L. Medical problems of adult horses, as ranked by equine practitioners. JAVMA. 198:1991;1745-1747
4. Bracher V., von Fellenberg J.L., Winder C.N., et al. An investigation of the incidence of chronic obstructive pulmonary disease (COPD) in random populations of Swiss horses. Equine Vet J. 23:1991;136-141
5. Larson V.L., Busch R.H. Equine tracheobronchial lavage: comparison of lavage cytologic features in horses with chronic obstructive pulmonary disease. Am J Vet Res. 46:1985;144-146
6. McPherson E.A., Lawson G.H.K., Murphy J.R., et al. Chronic obstructive pulmonary disease (COPD): identification of affected horses. Equine Vet J. 10:1978;47-53
7. Morris E.A., Seeherman H.J. Clinical evaluation of poor performance in the racehorse: the results of 275 evaluations. Equine Vet J. 23:1991;169-174
8. Winder N.C., von Fellenberg R. Chronic small airway disease in horses slaughtered in Switzerland. Schweiz Arch Tierheilkd. 129:1987;585-593
9. Costa L.R., Seahorn T.L., Moore R.M., et al. Correlation of clinical score, intrapleural pressure, cytologic findings of bronchoalveolar fluid, and histopathologic lesions of pulmonary tissue in horses with summer pasture-associated obstructive pulmonary disease. Am J Vet Res. 61:2000;167-173
10. Seahorn T.L., Beadle R.E. Summer pasture-associated obstructive pulmonary disease in horses: 21 cases (1983-1991). JAVMA. 202:1993;779-782
11. McPherson E.A., Lawson G.H., Murphy J.R., et al. Chronic obstructive pulmonary disease (COPD): identification of affected horses. Equine Vet J. 10:1978;47-53
12. Marti E., Gerber H., Essich G., et al. The genetic basis of equine allergic diseases 1. Chronic hypersensitivity bronchitis. Equine Vet J. 23:1991;457-460
13. Cook W.R., Rossdale P.D. The syndrome of 'broken wind' in the horse. Proc R Soc Med. 56:1963;972-977
14. Joubert P., Cordeau M.E., Boyer A., et al. Quantification of mRNA expression by peripheral neutrophils in an animal model of asthma. Am J Respir Crit Care Med. 165:2002;A317
15. Tesarowski D.B., Viel L., McDonell W.N. Pulmonary function measurements during repeated environmental challenge of horses with recurrent airway obstruction (heaves). Am J Vet Res. 57:1996;1214-1219
16. Thomson J.R., McPherson E.A. Effects of environmental control on pulmonary function of horses affected with chronic obstructive pulmonary disease. Equine Vet J. 16:1984;35-38
17. Cagney P., Gobert H.J. La Pousse. Baillères J. Dictionnaire vétérinaire. vol. 2:1904;554 Baillieres, Paris
18. Derksen F.J., Robinson N.E., Scott J.S., et al. Aerosolized Micropolyspora faeni antigen as a cause of pulmonary dysfunction in ponies with recurrent airway obstruction (heaves). J Vet Res. 49:1988;933-938
19. McGorum B.C., Dixon P.M., Halliwell R.E. Responses of horses affected with chronic obstructive pulmonary disease to inhalation challenges with mould antigens. Equine Vet J. 25:1993;261-267
20. McGorum B.C., Ellison J., Cullen R.T. Total and respirable airborne dust endotoxin concentrations in three equine management systems. Equine Vet J. 30:1998;430-434
21. Pirie R.S., Dixon P.M., Collie D.D., McGorum B.C. Pulmonary and systemic effects of inhaled endotoxin in control and heaves horses. Equine Vet J. 33:2001;311-318
22. Fairbairn S.M., Page C.P., Lees P., et al. Early neutrophil but not eosinophil or platelet recruitment to the lungs of allergic horses following antigen exposure. Clin Exp Allergy. 23:1993;821-828
23. Robinson N.E., Derksen F.J., Olszewski M.A., et al. The pathogenesis of chronic obstructive pulmonary disease of horses. Br Vet J. 152:1995;283-306
24. Picandet V, Leguillette R, Lavoie JP. Comparison of the effects of three corticosteroids in the treatment of horses affected by heaves. In: Proceedings of the 20th Annual Medical Forum of the American College of Veterinary Internal Medicine, Dallas, 2002. p. 771.
25. Tremblay G.M., Ferland C., Lapointe J.M., et al. Effect of stabling on bronchoalveolar cells obtained from normal and COPD horses. Equine Vet J. 25:1993;194-197
26. Barnes P.J. Pathophysiology of asthma. Br J Clin Pharmacol. 42:1996;3-10
27. Renauld J.C. New insights into the role of cytokines in asthma. J Clin Pathol. 54:2001;577-589
28. Robinson D.S., Hamid Q., Ying S., et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 326:1992;298-304
29. Giguere S., Viel L., Lee E., et al. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate. Vet Immunol Immunopathol. 85:2002;147-158
30. Lavoie J.P., Maghni K., Desnoyers M., et al. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. Am J Respir Crit Care Med. 164:2001;1410-1413
31. Chung K.F., Barnes P.J. Cytokines in asthma. Thorax. 54:1999;825-857
32. Franchini M., Gill U., von Fellenberg R., et al. Interleukin-8 concentration and neutrophil chemotactic activity in bronchoalveolar lavage fluid of horses with chronic obstructive pulmonary disease following exposure to hay. Am J Vet Res. 61:2000;1369-1374
33. Turlej R.K., Fievez L., Sandersen C.F., et al. Enhanced survival of lung granulocytes in an animal model of asthma: evidence for a role of GM-CSF activated STAT5 signaling pathway. Thorax. 56:2001;696-702
34. Lavoie J.P., Léguillette R., Charette L., et al. Comparison of dexamethasone and the LTD4 receptor antagonist L-708,738 in an equine COPD model. Am J Respir Crit Care Med. 161:2000;A185
35. Strieter R.M., Kasahara K., Allen R., et al. Human neutrophils exhibit disparate chemotactic factor gene expression. Biochem Biophys Res Commun. 173:1990;725-730
36. Bureau F., Delhalle S., Bonizzi G., et al. Mechanisms of persistent NF-kappa B activity in the bronchi of an animal model of asthma. J Immunol. 165:2000;5822-5830
37. Sandersen C., Bureau F., Turlej R., et al. Homodimer activity in distal airway cells determines lung dysfunction in equine heaves. Vet Immunol Immunopathol. 80:2001;315-326
38. Gerger H. Chronic pulmonary disease in the horse. Equine Vet J. 5:1973;26-33
39. Lavoie J.P. Chronic obstructive pulmonary disease. Robinson N.E. Current therapy in equine veterinary medicine. vol. 4:1997;431-435 WB Saunders, Philadelphia
40. Mair T.S., Derksen F.J. Chronic obstructive pulmonary disease: a review. Equine Vet Educ. 2:2000;53-62
41. Gray P.R., Derksen F.J., Robinson N.E., et al. The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves. Am Rev Respir Dis. 140:1989;154-160
42. Marr K.A., Lees P., Page C.P., et al. Inhaled leukotrienes cause bronchoconstriction and neutrophil accumulation in horses. Res Vet Sci. 64:1998;219-224
43. Broadstone R.V., Scott J.S., Derksen F.J., et al. Effects of atropine in ponies with recurrent airway obstruction. J Appl Physiol. 65:1988;2720-2725
44. Derksen F.J., Olszewski M., Robinson N.E., et al. Use of a hand-held, metered-dose aerosol delivery device to administer pirbuterol acetate to horses with 'heaves'. Equine Vet J. 28:1996;306-310
45. Lapointe J.M., Lavoie J.P., Vrins A. Effects of triamcinolone acetonide on pulmonary function and bronchoalveolar lavage cytologic features in horses with chronic obstructive pulmonary disease. Am J Vet Res. 54:1993;1310-1316
46. Murphy J.R., McPherson E.A., Dixon P.M. Chronic obstructive pulmonary disease (COPD): effects of bronchodilator drugs on normal and affected horses. Equine Vet J. 12:1980;10-14
47. Muylle E., Oyaert W. Lung function tests in obstructive pulmonary disease in horses. Equine Vet J. 5:1973;37-44
48. Broadstone R.V., LeBlanc P.H., Derksen F.J., et al. In vitro responses of airway smooth muscle from horses with recurrent airway obstruction. Pulm Pharmacol. 4:1991;191-202
49. LeBlanc P.H., Broadstone R.V., Derksen F.J., et al. In vitro responses of distal airways in horses with recurrent airway obstruction. Am J Vet Res. 52:1991;999-1003
50. Wang Z., Yu M., Robinson N.E., et al. Exogenous but not endogenous PGE2 modulates pony tracheal smooth muscle contractions. Pulm Pharmacol. 5:1992;225-231
51. Wang Z.W., Yu M.F., Robinson N.E., et al. Acetylcholine release from airway cholinergic nerves in horses with heaves, an airway obstructive disease. Am J Respir Crit Care Med. 151:1995;830-835
52. Yu M., Wang Z., Robinson N.E., et al. Inhibitory nerve distribution and mediation of NANC relaxation by nitric oxide in horse airways. J Appl Physiol. 76:1994;339-344
53. Yu M.F., Wang Z.W., Robinson N.E., et al. Modulation of bronchial smooth muscle function in horses with heaves. J Appl Physiol. 77:1994;2149-2154
54. Olszewski M.A., Zhang X.Y., Robinson N.E. Pre- and postjunctional effects of inflammatory mediators in horse airways. Am J Physiol. 277:1999;L327-L333
55. Kaup F.J., Drommer W., Damsch S., et al. Ultrastructural findings in horses with chronic obstructive pulmonary disease (COPD) II: Pathomorphological changes of the terminal airways and the alveolar region. Equine Vet J. 22:1990;349-355
56. Gerber V., King M., Schneider D.A., et al. Tracheobronchial mucus viscoelasticity during environmental challenge in horses with recurrent airway obstruction. Equine Vet J. 32:2000;411-417
57. Jefcoat A.M., Hotchkiss J.A., Gerber V., et al. Persistent mucin glycoprotein alterations in equine recurrent airway obstruction. Am J Physiol Lung Cell Mol Physiol. 281:2001;L704-L712
58. Nyman G., Lindberg R., Weckner D., et al. Pulmonary gas exchange correlated to clinical signs and lung pathology in horses with chronic bronchiolitis. Equine Vet J. 23:1991;253-260
59. Beech J. Chronic obstructive pulmonary disease. Vet Clin North Am Equine Pract. 7:1991;79-91
60. Breeze R.G. Heaves. The problem of disease definition. Vet Clin North Am Large Anim Pract. 1:1979;219-230
61. McPherson E.A., Thompson J.R. Chronic obstructive pulmonary disease in the horse I: Nature of the disease. Equine Vet J. 15:1983;203-206
62. Kaup F.J., Drommer W., Deegen E. Ultrastructural findings in horses with chronic obstructive pulmonary disease (COPD) I: Alterations of the larger conducting airways. Equine Vet J. 22:1990;343-348
63. Raulo S.M., Sorsa T.A., Maisi P.S. Concentrations of elastinolytic metalloproteinases in respiratory tract secretions of healthy horses and horses with chronic obstructive pulmonary disease. Am J Vet Res. 61:2000;1067-1073
64. Fernandes D.J., Xu K.F., Stewart A.G. Anti-remodelling drugs for the treatment of asthma: requirement for animal models of airway wall remodelling. Clin Exp Pharmacol Physiol. 28:2001;619-629
65. Bruce E.H. Interstitial pneumonia in horses. Compend Contin Educ Pract Vet. 17:1995;1145-1153
66. Donaldson M.T., Beech J., Ennulat D., et al. Interstitial pneumonia and pulmonary fibrosis in a horse. Equine Vet J. 30:1998;173-175
67. McGorum B.C., Dixon P.M., Halliwell R.E., et al. Comparison of cellular and molecular components of bronchoalveolar lavage fluid harvested from different segments of the equine lung. Res Vet Sci. 55:1993;57-59
68. Derksen F.J., Brown C.M., Sonea I., et al. Comparison of transtracheal aspirate and bronchoalveolar lavage cytology in 50 horses with chronic lung disease. Equine Vet J. 21:1989;23-26
69. Beech J. Bronchoalveolar lavages. Equine respiratory disorders. 1991;53-69 Lea & Febiger, Philadelphia
70. Vrins A., Doucet M., Nunez-Ochoa L. A retrospective study of bronchoalveolar lavage cytology in horses with clinical findings of small airway disease. Zentralbl Veterinarmed A. 38:1991;472-479
71. Jackson C.A., Berney C., Jefcoat A.M., et al. Environment and prednisone interactions in the treatment of recurrent airway obstruction (heaves). Equine Vet J. 32:2000;432-438
72. Robinson NE, Wilson MR. Evidence-based medicine applied to heaves. In: Proceedings of the Second World Equine Airways Symposium and 19th Comparative Respiratory Society Meeting, 2001. p. 1-11.
73. Art T., McGorum B.C., Lekeux P. Environmental control of respiratory disease. Lekeux P. Equine respiratory diseases. 2002;International Veterinary Information Service (http://www.ivis.org), Ithaca, NY
74. Ammann V.J., Vrins A.A., Lavoie J.P. Effects of inhaled beclomethasone dipropionate on respiratory function in horses with chronic obstructive pulmonary disease (COPD). Equine Vet J. 30:1998;152-157
75. Derksen F.J., Scott J.S., Slocombe R.F., et al. Micropolyspora faeni causes airway inflammation but not hyperresponsiveness in sensitized ponies. J Appl Physiol. 62:1987;1398-1404
76. Théoret C., Lavoie J.P., Bélanger D., et al. Le COPD chez le cheval: adhésion aux recommandations et efficacité thérapeutique. Méd Vét Québec. 22:1992;88-89
77. Vandenput S., Istasse L., Nicks B., et al. Airborne dust and aeroallergen concentrations in different sources of feed and bedding for horses. Vet Q. 19:1997;154-158
78. Fairbairn S.M., Lees P., Page C.P., et al. Duration of antigen-induced hyperresponsiveness in horses with allergic respiratory disease and possible links with early airway obstruction. J Vet Pharmacol Ther. 16:1993;469-476
79. Barnes P.J. New directions in allergic diseases: mechanism-based anti-inflammatory therapies. J Allergy Clin Immunol. 106:2000;5-16
80. Barnes P.J. Molecular mechanisms of steroid action in asthma. J Allergy Clin Immunol. 97:1996;159-168
81. Eyre P., Elmes P.J., Strickland S. Corticosteroid-potentiated vascular responses of the equine digit: a possible pharmacologic basis for laminitis. Am J Vet Res. 40:1979;135-138
82. French K., Pollitt C.C., Pass M.A. Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses. J Vet Pharmacol Ther. 23:2000;287-292
83. Slone D.E., Purohit R.C., Ganjam V.K., et al. Sodium retention and cortisol (hydrocortisone) suppression caused by dexamethasone and triamcinolone in equids. Am J Vet Res. 44:1983;280-283
84. Rush B.R., Worster A.A., Flaminio M.J., et al. Alteration in adrenocortical function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am J Vet Res. 59:1998;1044-1047
85. Mair T.S. Bacterial pneumonia associated with corticosteroid therapy in three horses. Vet Rec. 138:1996;205-207
86. Traub-Dargatz J.L., McKinnon A.O., Thrall M.A., et al. Evaluation of clinical signs of disease, bronchoalveolar and tracheal wash analysis, and arterial blood gas tensions in 13 horses with chronic obstructive pulmonary disease treated with prednisone, methyl sulfonmethane, and clenbuterol hydrochloride. Am J Vet Res. 53:1992;1908-1916
87. Robinson N.E., Jackson C., Jefcoat A., et al. Efficacy of three corticosteroids for the treatment of heaves. Equine Vet J. 34:2002;17-22
88. Robinson NE, Jackson CA, Peroni D. Why is oral prednisone ineffective for treatment of heaves? In: Proceedings of the 46th Annual American Association of Equine Practitioners Convention, San Antonio, 2000. p. 266-7.
89. Picandet V, Leguillette R, Lavoie JP. Comparison of the effects of isoflupredone and dexamethasone in the treatment of heaves-affected horses, in press.
90. Rush B.R., Raub E.S., Rhoads W.S., et al. Pulmonary function in horses with recurrent airway obstruction after aerosol and parenteral administration of beclomethasone dipropionate and dexamethasone, respectively. Am J Vet Res. 59:1998;1039-1043
91. Ammann VJ, Lavoie JP, Vrins AA. Effects of béclométhasone dipropionate in horses with chronic obstructive pulmonary disease (COPD). In: Proceedings 13th Annual American College of Veterinary Internal Medicine Forum, 1995. p. 1037.
92. Barnes P.J. The role of inflammation and anti-inflammatory medication in asthma. Respir Med. 96:(Suppl A):2002;S9-S15
93. Derksen F.J. Chronic obstructive pulmonary disease (heaves) as an inflammatory condition. Equine Vet J. 25:1993;257-258
94. Garrett J., Kolbe J., Richards G., et al. Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: what lessons have been learned? Thorax. 50:1995;303-311
95. Kelsen S.G., Church N.L., Gillman S.A., et al. Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial. J Asthma. 36:1999;703-715
96. Olszewski M.A., Robinson N.E., Yu M.F., et al. Effects of hydrogen peroxide on isolated trachealis muscle of horses. Am J Vet Res. 56:1995;1479-1485
97. Ducharme N.G., Fubini S.L. Gastrointestinal complications associated with the use of atropine in horses. JAVMA. 182:1983;229-231
98. Pearson E.G., Riebold T.W. Comparison of bronchodilators in alleviating clinical signs in horses with chronic obstructive pulmonary disease. JAVMA. 194:1989;1287-1291
99. Duvivier D.H., Votion D., Vandenput S., et al. Airway response of horses with COPD to dry powder inhalation of ipratropium bromide. Vet J. 154:1997;149-153
100. Robinson N.E., Derksen F.J., Berney C., et al. The airway response of horses with recurrent airway obstruction (heaves) to aerosol administration of ipratropium bromide. Equine Vet J. 25:1993;299-303
101. Erichsen D.F., Aviad A.D., Schultz R.H., et al. Clinical efficacy and safety of clenbuterol HCl when administered to effect in horses with chronic obstructive pulmonary disease (COPD). Equine Vet J. 26:1994;331-336
102. Derksen F.J., Olszewski M.A., Robinson N.E., et al. Aerosolized albuterol sulfate used as a bronchodilator in horses with recurrent airway obstruction. Am J Vet Res. 60:1999;689-693
103. Tesarowski D.B., Viel L., McDonell W.N., et al. The rapid and effective administration of a beta 2-agonist to horses with heaves using a compact inhalation device and metered-dose inhalers. Can Vet J. 35:1994;170-173
104. Entzian P., Bitter-Suermann S., Burdon D., et al. Differences in the anti-inflammatory effects of theophylline and pentoxifylline: important for the development of asthma therapy? Allergy. 53:1998;749-754
105. McKiernan B.C., Koritz G.D., Scott J.S., et al. Plasma theophylline concentration and lung function in ponies with recurrent obstructive lung disease. Equine Vet J. 22:1990;194-197
106. Leguillette R., Desevaux C., Lavoie J.P. Effects of pentoxifylline on pulmonary function and results of cytologic examination of bronchoalveolar lavage fluid in horses with recurrent airway obstruction. Am J Vet Res. 63:2002;459-463
107. Turgut K., Sasse H.H. Influence of clenbuterol on mucociliary transport in healthy horses and horses with chronic obstructive pulmonary disease. Vet Rec. 125:1989;526-530
108. Jean D, Lavoie JP, Vrins A. Respiratory effects of massive saline infusion in COPD horses. In: Proceedings of the 14th Annual American College of Veterinary Internal Medicine Forum, San Antonio, 1996. p. 770.
109. Aviza G.A., Ainsworth D.M., Eicker S.W. Outcome of horses diagnosed and treated for heaves (recurrent airway obstruction). Equine Vet Educ. 3:2001;318-320